The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020.
Saved in:
| Title: | The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020. |
|---|---|
| Authors: | Knight GM; Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. gwen.knight@lshtm.ac.uk., Pham TM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK., Stimson J; Healthcare Associated Infections and Antimicrobial Resistance Division, National Infection Service, Public Health England, Colindale, London, UK., Funk S; Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Jafari Y; Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Pople D; Healthcare Associated Infections and Antimicrobial Resistance Division, National Infection Service, Public Health England, Colindale, London, UK., Evans S; Healthcare Associated Infections and Antimicrobial Resistance Division, National Infection Service, Public Health England, Colindale, London, UK., Yin M; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.; National University of Singapore Department of Medicine, Singapore, Singapore., Brown CS; Healthcare Associated Infections and Antimicrobial Resistance Division, National Infection Service, Public Health England, Colindale, London, UK., Bhattacharya A; Healthcare Associated Infections and Antimicrobial Resistance Division, National Infection Service, Public Health England, Colindale, London, UK., Hope R; Healthcare Associated Infections and Antimicrobial Resistance Division, National Infection Service, Public Health England, Colindale, London, UK., Semple MG; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.; Respiratory Medicine, Alder Hey Children's NHS Foundation Trust, Liverpool, UK., Read JM; Lancaster Medical School, Lancaster University, Lancaster, UK., Cooper BS; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK., Robotham JV; Healthcare Associated Infections and Antimicrobial Resistance Division, National Infection Service, Public Health England, Colindale, London, UK.; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford in Partnership with PHE, Oxford, UK. |
| Corporate Authors: | ISARIC4C Investigators, CMMID COVID-19 Working Group |
| Source: | BMC infectious diseases [BMC Infect Dis] 2022 Jun 18; Vol. 22 (1), pp. 556. Date of Electronic Publication: 2022 Jun 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2334 |
|---|---|
| DOI: | 10.1186/s12879-022-07490-4 |
